Previous close | 17.51 |
Open | 17.46 |
Bid | 17.62 x 100 |
Ask | 17.71 x 100 |
Day's range | 17.13 - 17.70 |
52-week range | 5.12 - 21.60 |
Volume | |
Avg. volume | 598,244 |
Market cap | 1.648B |
Beta (5Y monthly) | 0.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.54 |
Earnings date | 08 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 33.60 |
Performance Analysis and Future Clinical Prospects
BOULDER, Colo., May 10, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET.
BOULDER, Colo., May 09, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.